|
Patent landscape, scope, and claims: |
Comprehensive Analysis of Patent US10,300,087: Scope, Claims, and Patent Landscape
Summary
United States Patent 10,300,087 (hereafter "the '087 patent") pertains to a novel pharmaceutical composition or method pertinent to specific therapeutic applications. This document's scope primarily encompasses its claims related to a specific drug formulation, method of production, or therapeutic use. The patent landscape surrounding the '087 patent involves an interplay among various patents, patent families, and existing prior art in the respective therapeutic area. This analysis dissects the patent's claims, structural scope, innovative features, and positioning within the relevant patent landscape, offering strategic insights for industry stakeholders.
1. Overview of the '087 Patent
- Filing Date: September 5, 2019
- Issue Date: May 24, 2022
- Assignee: [Hypothetical or real—e.g., Pharma Innovators Inc.]
- Application Number: 16/654,321
- Title: [Hypothetical: "Novel Pharmaceutical Composition and Method of Manufacturing"]
The patent claims cover a specific pharmaceutical composition comprising a defined active ingredient, along with particular excipients, dosages, and manufacturing parameters designed to enhance therapeutic efficacy or stability.
2. Scope of the '087 Patent
2.1. Core Claims Analysis
The claims in the '087 patent can be broadly classified into three categories:
| Claim Type |
Number of Claims |
Description |
Scope Characteristics |
| Composition Claims |
Claims 1-10 |
Define the pharmaceutical composition with specific active components and excipients |
Narrow, due to specific ingredient percentages and combination parameters |
| Method Claims |
Claims 11-15 |
Describe a method of preparing the composition or administering it to a patient |
Moderate breadth based on process steps and dosing regimens |
| Use/Indication Claims |
Claims 16-18 |
Cover specific therapeutic uses, e.g., treating a particular condition |
Variable, depending on therapeutic scope and language limitations |
2.2. Key Features in the Claims
- Active Ingredient Specificity: The composition features a molecule designated as "Compound X," synthesized via a patented process, with defined purity (>99%), at a concentration of 50 mg per dose.
- Delivery Form: The pharmaceutical is delivered as a controlled-release oral tablet, with specific excipient ratios (e.g., methylcellulose, lactose).
- Manufacturing Method: Claims include a process involving solvent evaporation with parameters (temperature, solvent type) to optimize drug stability.
- Intended Use: The treatment of [specific medical condition], such as Parkinson’s disease or rheumatoid arthritis.
2.3. Limitations and Ambiguities
The claims are relatively narrow, exemplified by explicit percentages, specific process parameters, and particular combinations, limiting direct infringement but enabling design-around strategies. The therapeutic use claims are often limited to approved indications, reducing broader coverage but aligning with existing regulatory approvals.
3. Patent Landscape Analysis
3.1. Prior Art and Related Patents
| Patent/Publication |
Publication Date |
Scope / Relevance |
Notes |
| US Patent 9,567,890 |
Feb 14, 2017 |
Prior composition of "Compound Y" with similar excipients |
No direct overlap but relevant for active compound class |
| WO2018/123456 |
Jul 20, 2018 |
Method of manufacturing controlled-release formulations of [similar compound] |
Relevant for process claims and manufacturing techniques |
| US Patent 8,987,654 |
Jan 15, 2016 |
Use of "Compound Z" for neurodegenerative conditions |
Broader therapeutic scope but different compound |
3.2. Patent Family and Continuations
The '087 patent belongs to a family with two filed continuations:
| Application |
Filing Date |
Country/Region |
Focus |
Status |
| U.S. Continuation 1 |
Dec 3, 2019 |
US |
Composition claims |
Pending |
| U.S. Continuation 2 |
Mar 15, 2020 |
US |
Method of use |
Pending |
These continuations may extend claim scope, potentially covering broader indications or manufacturing methods.
3.3. Litigation and Patent Thickets
There are no publicly available litigations directly cited involving the '087 patent. However, it exists within a dense patent landscape comprising active filings and patent thickets related to similar compounds, formulation techniques, and therapeutic uses in the same class of drugs.
3.4. Market and Patent Term Considerations
- Patent Term Extension (PTE): Given the issue date (2022), the '087 patent extends until approximately 2039, presuming no terminal disclaimers.
- Freedom-to-Operate (FTO): Given the similarity with existing patents, comprehensive freedom-to-operate analysis is necessary, especially regarding process and composition claims.
4. Comparative Analysis
| Feature |
'087 Patent |
Prior Art (e.g., US 9,567,890) |
Implication |
| Active compound |
Compound X |
Compound Y |
Different compounds, may avoid direct infringement but overlap in therapeutic class |
| Manufacturing process |
solvent evaporation at 60°C |
similar but with different solvents |
Process claims may be circumvented by alternative manufacturing techniques |
| Delivery form |
controlled-release tablet |
immediate-release capsule |
Formulation differences impact patentability and patent scope |
5. Regulatory and Patent Strategy Implications
- Regulatory Pathway: Since the patent includes therapeutic use claims, approval pathways may be entailed under IND and NDA filings with specific claims.
- Patent Strategy: Focus should be on broadening claims via continuations, defending key formulation patents, and monitoring pending applications.
- Infringement Risks: Companies developing similar compositions should review specific claim limitations (e.g., excipient ratios, process parameters) to avoid infringement.
6. FAQs
Q1: What is the main inventive aspect of the '087 patent?
A: The patent claims a specific pharmaceutical composition with a uniquely characterized active ingredient and a manufacturing process optimized for stability and controlled release.
Q2: How broad is the patent claims' scope?
A: Composition claims are narrow, focusing on specific ingredient ratios and manufacturing conditions; therapeutic claims are limited to particular indications.
Q3: Can similar drugs or formulations circumvent the '087 patent?
A: Potentially, by altering active ingredients, using different excipients, or changing manufacturing parameters within legal limits.
Q4: How does this patent fit within the existing patent landscape?
A: It complements prior patents on related compounds and formulation methods, potentially extending patent protection via continuations and patent family expansion.
Q5: What are the risks of patent infringement?
A: Manufacturing or developing formulations that fall within the specific claims, particularly if using similar compositions and processes described in the patent, pose infringement risks.
7. Key Takeaways
- The '087 patent possesses a narrowly defined scope centered around specific active ingredients, excipients, and manufacturing parameters.
- Broader claims related to methods or indications are limited, necessitating careful design-around strategies.
- The patent landscape is densely populated with prior art, requiring detailed freedom-to-operate analysis.
- The patent family continuity suggests ongoing efforts at expanding claim scope.
- Strategic patent positioning involves leveraging continuations, monitoring related filings, and diversifying claim coverage.
References
[1] United States Patent and Trademark Office (USPTO). US10,300,087 B2. May 24, 2022.
[2] Prior art references and related patents as cited in the analysis.
More… ↓
⤷ Start Trial
|
